Tower View Wealth Management LLC / EW
Tower View Wealth Management LLC’s Edwards Lifesciences Corp Position
Does Tower View Wealth Management LLC own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 42.5K shares worth $5M in Q1 2022; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q1 2022
Shares
42.5K
% of Portfolio
+2.69%
Quarters Held
14
position exited
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2022 | 42.5K | $5M | +2.69% |
| Q4 2021 | 42.0K | $5M | +2.77% |
| Q3 2021 | 41.9K | $5M | +2.63% |
| Q2 2021 | 42.0K | $4M | +2.20% |
| Q1 2021 | 42.0K | $4M | +1.92% |
| Q4 2020 | 41.7K | $4M | +2.16% |
| Q3 2020 | 40.1K | $3M | +2.09% |
| Q2 2020 | 39.9K | $3M | +2.02% |
| Q1 2020 | 13.0K | $2M | +2.22% |
| Q4 2019 | 12.9K | $3M | +2.28% |
| Q3 2019 | 13.4K | $3M | +2.43% |
| Q2 2019 | 13.4K | $2M | +2.11% |
| Q1 2019 | 13.6K | $3M | +2.31% |
| Q4 2018 | 13.9K | $2M | +2.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tower View Wealth Management LLC’s full portfolio or all institutional holders of EW.